151 related articles for article (PubMed ID: 38774675)
1. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF; Messina NL; McDonald E; Orsini F; Barry S; Bonten M; Campbell J; Croda J; Croda MG; Dalcolmo M; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Perrett KP; Post JJ; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Davidson A; Curtis N;
EClinicalMedicine; 2024 Jun; 72():102616. PubMed ID: 38774675
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.
Pittet LF; Moore CL; McDonald E; Barry S; Bonten M; Campbell J; Croda J; Dalcolmo M; Davidson A; Douglas MW; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; de Oliveira RD; Perrett KP; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Messina NL; Curtis N;
EClinicalMedicine; 2023 Oct; 64():102203. PubMed ID: 37719417
[TBL] [Abstract][Full Text] [Related]
3. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial.
Dos Santos PCP; Messina NL; de Oliveira RD; da Silva PV; Puga MAM; Dalcolmo M; Dos Santos G; de Lacerda MVG; Jardim BA; de Almeida E Val FF; Curtis N; Andrews JR; Croda J
Lancet Infect Dis; 2024 Jun; 24(6):594-601. PubMed ID: 38423021
[TBL] [Abstract][Full Text] [Related]
4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
5. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
Pittet LF; Messina NL; Orsini F; Moore CL; Abruzzo V; Barry S; Bonnici R; Bonten M; Campbell J; Croda J; Dalcolmo M; Gardiner K; Gell G; Germano S; Gomes-Silva A; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Lacerda MVG; Lee KJ; Lucas M; Lynn DJ; Manning L; Marshall HS; McDonald E; Munns CF; Nicholson S; O'Connell A; de Oliveira RD; Perlen S; Perrett KP; Prat-Aymerich C; Richmond PC; Rodriguez-Baño J; Dos Santos G; da Silva PV; Teo JW; Villanueva P; Warris A; Wood NJ; Davidson A; Curtis N;
N Engl J Med; 2023 Apr; 388(17):1582-1596. PubMed ID: 37099341
[TBL] [Abstract][Full Text] [Related]
6. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
8. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial).
Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Guimarães Lacerda MV; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N;
BMJ Open; 2021 Oct; 11(10):e052101. PubMed ID: 34711598
[TBL] [Abstract][Full Text] [Related]
9. Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.
Messina NL; Pittet LF; Gardiner K; Freyne B; Francis KL; Zufferey C; Abruzzo V; Morrison C; Allen KJ; Flanagan KL; Ponsonby AL; Robins-Browne R; Shann F; South M; Vuillermin P; Donath S; Casalaz D; Curtis N
J Infect Dis; 2021 Oct; 224(7):1115-1127. PubMed ID: 34146093
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial.
Upton CM; van Wijk RC; Mockeliunas L; Simonsson USH; McHarry K; van den Hoogen G; Muller C; von Delft A; van der Westhuizen HM; van Crevel R; Walzl G; Baptista PM; Peter J; Diacon AH;
EClinicalMedicine; 2022 Jun; 48():101414. PubMed ID: 35582122
[TBL] [Abstract][Full Text] [Related]
11. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
Satti I; Marshall JL; Harris SA; Wittenberg R; Tanner R; Lopez Ramon R; Wilkie M; Ramos Lopez F; Riste M; Wright D; Peralta Alvarez MP; Williams N; Morrison H; Stylianou E; Folegatti P; Jenkin D; Vermaak S; Rask L; Cabrera Puig I; Powell Doherty R; Lawrie A; Moss P; Hinks T; Bettinson H; McShane H
Lancet Infect Dis; 2024 Apr; ():. PubMed ID: 38621405
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination.
Villanueva P; Crawford NW; Croda MG; Collopy S; Jardim BA; de Almeida Pinto Jardim T; Manning L; Lucas M; Marshall H; Prat-Aymerich C; Sawka A; Sharma K; Troeman D; Wadia U; Warris A; Wood N; Messina NL; Curtis N; Pittet LF
Heliyon; 2023 Apr; 9(4):e15241. PubMed ID: 37113782
[TBL] [Abstract][Full Text] [Related]
13. Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trial.
Pittet LF; Messina NL; Gardiner K; Freyne B; Abruzzo V; Francis KL; Morrison C; Zufferey C; Vuillermin P; Allen KJ; Ponsonby AL; Robins-Browne R; Shann F; Flanagan KL; Phillips R; Donath S; Casalaz D; Curtis N
Allergy; 2022 Mar; 77(3):956-965. PubMed ID: 34309859
[TBL] [Abstract][Full Text] [Related]
14. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
[TBL] [Abstract][Full Text] [Related]
15. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
[TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
[TBL] [Abstract][Full Text] [Related]
17. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.
Prentice S; Nassanga B; Webb EL; Akello F; Kiwudhu F; Akurut H; Elliott AM; Arts RJW; Netea MG; Dockrell HM; Cose S;
Lancet Infect Dis; 2021 Jul; 21(7):993-1003. PubMed ID: 33609457
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Pittet LF; Cox L; Freyne B; Germano S; Bonnici R; Gardiner K; Donath S; Collins CL; Casalaz D; Robins-Browne R; Flanagan KL; Messina NL; Curtis N
Vaccine; 2022 Feb; 40(9):1334-1341. PubMed ID: 35105495
[TBL] [Abstract][Full Text] [Related]
19. Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Wilkie M; Tanner R; Wright D; Lopez Ramon R; Beglov J; Riste M; Marshall JL; Harris SA; Bettencourt PJG; Hamidi A; van Diemen PM; Moss P; Satti I; Wyllie D; McShane H
Sci Rep; 2022 May; 12(1):7808. PubMed ID: 35552463
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
